Credit Suisse »

Apellis Pharmaceuticals shares owned by Credit Suisse

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 86k 59.86
2023-09-30 $3.3M 87k 38.04
2023-06-30 $8.6M 94k 91.10
2023-03-31 $5.5M 84k 65.96
2022-12-31 $4.0M 77k 51.71
2022-09-30 $5.3M 77k 68.30
2022-06-30 $2.9M 65k 45.20
2022-03-31 $3.6M 70k 50.81
2021-12-31 $3.0M 63k 47.31
2021-09-30 $2.0M 59k 32.97
2021-06-30 $2.9M 46k 63.24
2021-03-31 $2.1M 48k 42.92
2020-12-31 $5.2M 91k 57.37
2020-09-30 $2.5M 105k 23.81
2020-06-30 $4.2M 128k 32.65
2020-03-31 $1.5M 55k 26.77
2019-12-31 $1.9M 60k 30.71
2019-09-30 $2.1M 52k 40.00
2019-06-30 $1.1M 29k 40.00
2019-03-31 $418k 24k 17.54
2018-12-31 $259k 20k 13.22
2018-09-30 $241k 14k 17.76
2018-06-30 $321k 15k 22.10